Amgen
One of the world's largest biotech companies, Amgen makes drugs that treat high cholesterol, leukemia, and osteoporosis, among many other medical problems.
Courtesy of Amgen
Company Information
As of 6/5/23
Country
U.S.
Headquarters
Thousand Oaks, Calif.
Industry
Pharmaceuticals
CEO
Robert A. Bradway
Website
Company Type
Public
Ticker
AMGN
Revenues ($M)
$26,323
Profits ($M)
$6,552
Market Value ($M)
$129,089
Employees
25,200
Market value as of March 31, 2023.
World's Most Admired Companies
Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
-
Previous All-Star Rank
-
Industry Rank
8
Previous Industry Rank
7
Overall Score
6.87
Innovation
11
People Management
10
Use of Corporate Assets
5
Social Responsibility
9
Quality of Management
6
Financial Soundness
6
Long-Term Investment Value
9
Quality of Products/Services
6
Global Competitiveness
15
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
10.28
EPS % Change (from 2020)
-16.5%
EPS % Change (5 year annual rate)
0.1%
EPS % Change (10 year annual rate)
9.8%
Total Return
Total Return to Investors (2021)
1%
Total Return to Investors (5 year, annualized)
12.2%
Total Return to Investors (10 year, annualized)
16.2%
Key Financials (Last Fiscal Year)
($ Millions)
% change
Revenues ($M)
$25,424
8.8%
Profits ($M)
$7,264
-7.4%
Assets ($M)
$62,948
-
Total Stockholder Equity ($M)
$9,409
-
Profit Ratios
Profit as % of Revenues
28.6%
Profits as % of Assets
11.5%
Profits as % of Stockholder Equity
77.2%
Lists ranking Amgen
Latest news for Amgen
